Growth Investors & VC Firms in United States

518 firms in this list, with a median first check of $1M. 110 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
AT Atlantic Vantage Point ASBFDMFR11 people	88🔒	Paris	FR	Seed–Late Stage	$1M – $20M	+ Add to CRM
BP BPOC DJGAGAMT11 people	88🔒	Chicago	US	Growth	$25M – $100M	+ Add to CRM
CA Calera Capital BFETJHJF11 people	88🔒	San Francisco	US	Growth	$50M – $250M	+ Add to CRM
CA Capital Southwest Corporation JSRKGESK11 people	88🔒	Dallas	US	Growth	$5M – $45M	+ Add to CRM
CH Chrysalis Ventures DADAIBWS5 people	88🔒	Louisville	US	Series A–Late Stage	$1M – $10M	+ Add to CRM
DE Delta-v Capital CBDWDSGM11 people	88🔒	Boulder	US	Growth	$2M – $10M	+ Add to CRM
EL Elsewhere Partners CPJTNSSC11 people	88🔒	Austin	US	Growth	$20M – $50M	+ Add to CRM
EQ EQT Life Sciences APFVFAJR11 people	88🔒	Amsterdam	NL	Series A–Late Stage	$10.8M – $64.8M	+ Add to CRM
EV EV Private Equity EGESGHHT11 people	88🔒	Stavanger	NO	Growth	$5M – $30M	+ Add to CRM
FR Frazier Healthcare Partners BMBKCRKB11 people	88🔒	Seattle	US	Growth	$50M – $400M	+ Add to CRM
FR Frontenac ECJRMSRW11 people	88🔒	Chicago	US	Growth	$25M – $75M	+ Add to CRM
GI Gilde Healthcare AFEDGPHD11 people	88🔒	Utrecht	NL	Seed–Late Stage	$1.1M – $32.4M	+ Add to CRM
HE Hercules Capital, Inc. BJCJGPJB11 people	88🔒	San Mateo	US	Seed–Late Stage	$500K – $50M	+ Add to CRM
HO Horizon Technology Finance KJKTTADR11 people	88🔒	Farmington	US	Growth	$3M – $50M	+ Add to CRM
IN Innova Capital Sp. z o.o. ABAPKMKK11 people · Leads rounds	88🔒	Warsaw	PL	Series A–Growth	$27M – $43.2M	+ Add to CRM
NA NaviMed Capital BSBCRRRS11 people	88🔒	Rosslyn	US	Growth	$5M – $30M	+ Add to CRM
VE Verdane BKCJDAEJ11 people	88🔒	Oslo	NO	Growth	$21.6M – $162M	+ Add to CRM
VI Viola Credit AGEFIVNM11 people	88🔒	Tel Aviv	IL	Growth–Late Stage	$2M – $50M	+ Add to CRM
WO World Innovation Lab (WiL) MMAKGIRT11 people	88🔒	Tokyo	JP	Seed–Late Stage	$5M – $30M	+ Add to CRM
YU Yuanta Investment BBJYMCSP11 people	88🔒	Seoul	KR	Seed–Late Stage	$1M – $15M	+ Add to CRM
AV Avego BioScience Capital Leads rounds	88🔒	Alpharetta	US	Series B–Late Stage	—	+ Add to CRM
CO Coinbase Ventures SA1 person	88🔒	Stamford	US	Pre-Seed–Growth	—	+ Add to CRM
GR Gray Line Partners EKRHJWJR5 people · Leads rounds	88🔒	Sammamish	US	Growth	—	+ Add to CRM
NE Neotribe Ventures SBSKNHNC5 people	88🔒	Menlo Park	US	Pre-Seed–Growth	—	+ Add to CRM

Atlantic Vantage Point

ParisSeed–Late Stage$1M – $20M

ASBFDMFR11 people

BPOC

ChicagoGrowth$25M – $100M

DJGAGAMT11 people

Calera Capital

San FranciscoGrowth$50M – $250M

BFETJHJF11 people

Capital Southwest Corporation

DallasGrowth$5M – $45M

JSRKGESK11 people

Chrysalis Ventures

LouisvilleSeries A–Late Stage$1M – $10M

DADAIBWS5 people

Delta-v Capital

BoulderGrowth$2M – $10M

CBDWDSGM11 people

Elsewhere Partners

AustinGrowth$20M – $50M

CPJTNSSC11 people

EQT Life Sciences

AmsterdamSeries A–Late Stage$10.8M – $64.8M

APFVFAJR11 people

EV Private Equity

StavangerGrowth$5M – $30M

EGESGHHT11 people

Frazier Healthcare Partners

SeattleGrowth$50M – $400M

BMBKCRKB11 people

Frontenac

ChicagoGrowth$25M – $75M

ECJRMSRW11 people

Gilde Healthcare

UtrechtSeed–Late Stage$1.1M – $32.4M

AFEDGPHD11 people

Hercules Capital, Inc.

San MateoSeed–Late Stage$500K – $50M

BJCJGPJB11 people

Horizon Technology Finance

FarmingtonGrowth$3M – $50M

KJKTTADR11 people

Innova Capital Sp. z o.o.

WarsawSeries A–Growth$27M – $43.2M

ABAPKMKK11 people

NaviMed Capital

RosslynGrowth$5M – $30M

BSBCRRRS11 people

Verdane

OsloGrowth$21.6M – $162M

BKCJDAEJ11 people

Viola Credit

Tel AvivGrowth–Late Stage$2M – $50M

AGEFIVNM11 people

World Innovation Lab (WiL)

TokyoSeed–Late Stage$5M – $30M

MMAKGIRT11 people

Yuanta Investment

SeoulSeed–Late Stage$1M – $15M

BBJYMCSP11 people

Avego BioScience Capital

AlpharettaSeries B–Late Stage

Coinbase Ventures

StamfordPre-Seed–Growth

SA1 person

Gray Line Partners

SammamishGrowth

EKRHJWJR5 people

Neotribe Ventures

Menlo ParkPre-Seed–Growth

SBSKNHNC5 people

Data sourced from public filings and firms' own websites — see our methodology.